Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A retinopathy caused by biallelic variants in the CNGB3 gene.
Biomarker and diagnostic research for CNGB3-related retinopathy has been reported in the published literature.
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
110 publications have been identified in PubMed for CNGB3-related retinopathy. Research spans Basic Science / Preclinical (35%), Review / Meta-Analysis (21%), and Epidemiology / Natural History (17%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 39 | 35% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 3:35 PM UTC
Common questions about CNGB3-related retinopathy
Research summaries |
23 |
21% |
Disease patterns and progression | 19 | 17% |
New treatment approaches | 13 | 12% |
Patient case studies | 10 | 9% |
Testing and diagnosis research | 4 | 4% |
Other research | 1 | 1% |
Clinical study results | 1 | 1% |
Sonehra (2026). [PMID: 42099125](https://pubmed.ncbi.nlm.nih.gov/42099125/). *Ophthalmic Genet*. [Basic Science / Preclinical]
Niaudet C (2026). [PMID: 41271176](https://pubmed.ncbi.nlm.nih.gov/41271176/). *Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology*. [Basic Science / Preclinical]
Aghajani J (2026). [PMID: 41217041](https://pubmed.ncbi.nlm.nih.gov/41217041/). *J Investig Med*. [Epidemiology / Natural History]
Wang X (2026). [PMID: 41662529](https://pubmed.ncbi.nlm.nih.gov/41662529/). *Proceedings of the National Academy of Sciences of the United States of America*. [Case Report / Case Series]
Mukundan A (2026). [PMID: 41316839](https://pubmed.ncbi.nlm.nih.gov/41316839/). *Ocular immunology and inflammation*. [Case Report / Case Series]
Ezra Kahtan B (2026). [PMID: 41490227](https://pubmed.ncbi.nlm.nih.gov/41490227/). *Retina*. [Review / Meta-Analysis]
Jia Y (2025). [PMID: 40517946](https://pubmed.ncbi.nlm.nih.gov/40517946/). *Progress in retinal and eye research*. [Review / Meta-Analysis]
Liu X (2025). [PMID: 39838377](https://pubmed.ncbi.nlm.nih.gov/39838377/). *Journal of translational medicine*. [Basic Science / Preclinical]
Rowe LW (2025). [PMID: 40319468](https://pubmed.ncbi.nlm.nih.gov/40319468/). *Expert opinion on pharmacotherapy*. [Basic Science / Preclinical]
Hoy SM (2025). [PMID: 40540142](https://pubmed.ncbi.nlm.nih.gov/40540142/). *Molecular diagnosis & therapy*. [Gene Therapy / Novel Therapeutics]